Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 9;15(12):2940–2951. doi: 10.1080/21645515.2019.1627159

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — hSBA GMTs one month following priming and booster 7.5 years after two dose priming of adolescents at 11–17 years of age* (Study 6).

Footnotes: * Two-dose schedule: 0–1, 0–2, or 0–6 months. Data from baseline through 6 months is from the 0–1 month schedule group; Persistence data from 18–23 months onwards is from pooled 0–1, 0–2, and 0–6 month schedules; Sample size = 93–127 in the pooled schedule booster cohort; CI = confidence interval, hSBA = serum bactericidal assay using human complement source, GMT = geometric mean antibody titer, fHbp = factor H binding protein, NadA = Neisseria adhesin A, PorA = porin A, NHBA = Neisserial Heparin Binding Antigen.